Doctor profile · Federal record
Dr. Stanley Marks, M.D.
Hematology & Oncology Physician (CMS: Hematology) · Pittsburgh, PA
- NPI 1477524924
- Accepts Medicare
- 53 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5115 Centre Ave, 3Rd Floor
Pittsburgh, PA 152321301
(412) 235-1020
fax (412) 235-1030 - Mailing address
-
2 Hot Metal St, Quantum One, N430
Pittsburgh, PA 152032348
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- January 11, 2010
- Year of graduation
- 1973 — 53 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Pennsylvania #MD015807E
- Medicaid
- PA #000655727
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477524924. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
383
Distinct HCPCS
4
Medicare allowed
$41,564
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 204 | 117 | $93 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 130 | 59 | $136 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 34 | 31 | $64 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 15 | 15 | $174 |
In context: peer comparison
Among 30 peers in this city , average services per provider: 85. This provider delivers 4.5× the peer median.Open Payments
Industry payments received
All-time total
$924
Transactions
11
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Stemline Therapeutics Inc. | 2 | $299.32 | |
| Exelixis Inc. | 1 | $174.00 | |
| BeiGene USA, Inc. | 2 | $148.27 | |
| AstraZeneca Pharmaceuticals LP | 4 | $140.94 | |
| Genmab U.S., Inc. | 1 | $134.68 | |
| Lilly USA, LLC | 1 | $26.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
526
Patients
32
Total drug cost
$2,483,117
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 86 | 21 | $2,077 |
| Imbruvica (Ibrutinib) | Brand | 53 | 0 | $685,988 |
| Ibrance (Palbociclib) | Brand | 49 | 0 | $657,482 |
| Calquence (Acalabrutinib Maleate) | Brand | 42 | 0 | $487,841 |
| Acyclovir | Generic | 36 | 0 | $486 |
| Brukinsa (Zanubrutinib) | Brand | 36 | 0 | $245,724 |
| Exemestane | Generic | 36 | 0 | $4,635 |
| Potassium Chloride | Generic | 31 | 11 | $549 |
| Pantoprazole Sodium | Generic | 29 | 0 | $205 |
| Gabapentin | Generic | 28 | 0 | $286 |
Hospital affiliations
Frequently asked questions
What is Dr. Stanley Marks's medical specialty?
Dr. Stanley Marks practices Hematology & Oncology Physician in Pittsburgh, PA.
Where does Dr. Stanley Marks practice?
Dr. Stanley Marks practices at 5115 Centre Ave, Pittsburgh, PA 152321301. Office phone: 4122351020.
What is Dr. Stanley Marks's NPI?
Dr. Stanley Marks's National Provider Identifier (NPI) is 1477524924, issued by NPPES.
Does Dr. Stanley Marks accept Medicare assignment?
Yes. Dr. Stanley Marks accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stanley Marks commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.